These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35092836)

  • 1. The effect of IGF-1 plasma concentration on COVID-19 severity.
    Hazrati E; Gholami M; Farahani RH; Ghorban K; Ghayomzadeh M; Rouzbahani NH
    Microb Pathog; 2022 Mar; 164():105416. PubMed ID: 35092836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of circulating insulin-like growth factor-1, heart-type fatty acid-binding protein, and endotrophin levels as prognostic markers of COVID-19 infection severity.
    Mohamed AA; Nour AA; Mosbah NM; Wahba ASM; Esmail OE; Eysa B; Heiba A; Samir HH; El-Kassas AA; Adroase AS; Elamir AY; Mahmoud GM; Rafaat RS; Hassan HA; El Abd YS
    Virol J; 2023 May; 20(1):94. PubMed ID: 37189123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Fan X; Yin C; Wang J; Yang M; Ma H; Jin G; Song M; Hu Z; Shen H; Hang D
    Eur J Epidemiol; 2021 Mar; 36(3):311-318. PubMed ID: 33420872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19.
    Feizollahi P; Matin S; Roghani SA; Mostafaei S; Safarzadeh E; Taghadosi M
    Inflammopharmacology; 2022 Feb; 30(1):199-205. PubMed ID: 35098386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length.
    Taher Al Barzin RMG; Ghafour Raheem S; Khudhur PK; Abdulkarimi R; Mohammadnejad E; Tabatabaee A
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):15-18. PubMed ID: 33040779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
    Sun H; Guo P; Zhang L; Wang F
    Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.
    Ilias I; Diamantopoulos A; Botoula E; Athanasiou N; Zacharis A; Tsipilis S; Jahaj E; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Front Endocrinol (Lausanne); 2021; 12():644055. PubMed ID: 34220703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cell Response during COVID-19 Infection and following SARS-CoV-2 Vaccination in Patients Admitted to Intensive Care Unit.
    Bahrini K; Stambouli N; Ben Azaiez M; Rebai A; Abid F; Romdhani C; Labben I; Gharsallah H; Ferjani M
    J Immunol Res; 2023; 2023():4059484. PubMed ID: 37144176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study.
    Çayan S; Uğuz M; Saylam B; Akbay E
    Aging Male; 2020 Dec; 23(5):1493-1503. PubMed ID: 32883151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.
    Nagant C; Ponthieux F; Smet J; Dauby N; Doyen V; Besse-Hammer T; De Bels D; Maillart E; Corazza F
    Int J Infect Dis; 2020 Dec; 101():342-345. PubMed ID: 33039609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.
    Ketenci S; Uygar Kalaycı M; Dündar B; Duranay R; Şükrü Aynacıoğlu A
    Int Immunopharmacol; 2022 Sep; 110():108939. PubMed ID: 35717836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Plasma 25(OH)D
    Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct systemic immune networks define severe
    Pignataro-Oshiro F; Figueiredo AB; Galdino NAL; Morais KLP; Dutra WO; Silva BGM; Feriani D; Abrantes FA; Silva ILAFE; Filho JS; Framil JVS; Cesca MG; Riechelmann RSP; Batista MV; Gollob KJ
    Front Immunol; 2022; 13():1052104. PubMed ID: 36700209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19.
    Li J; Rong L; Cui R; Feng J; Jin Y; Chen X; Xu R
    Ann Palliat Med; 2021 Apr; 10(4):3706-3714. PubMed ID: 33615814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.